The A.I. Wave Is Here

Deep Genomics, founded in 2015, is at the forefront of efforts by big companies, startups and university researchers to transform the economics of drug discovery. The problem is apparent. It typically takes several years and costs billions of dollars for pharmaceutical companies to bring a new drug to market.